Article
Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors.
Gynecologic oncology - 1 Sept 2021
Hillman R Tyler, Lin Douglas I, Lawson Barrett, Gershenson David M
Abstract excerpt
OBJECTIVE: The objective of this study was to determine the prevalence of predictive biomarkers associated with FDA-approved therapies in molecularly defined adult-type ovarian granulosa cell tumors (aGCTs). METHODS: We performed a retrospective cross-sectional cohort study of tumor profiles using the inclusion criteria of molecularly defined (FOXL2 c.C402G positive) aGCTs previously sequenced at Foundation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
